MedTrace Logo

Reduction of Inappropriate Implantable Cardioverter Defibrillator (ICD) Therapies in Primary Prevention Patients

NCT01217528 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 543

Last updated 2019-02-04

No results posted yet for this study

Summary

The purpose of this study is to determine efficacy of a dedicated programming concept for avoidance of inappropriate implantable cardioverter defibrillator (ICD) therapies in patient with primary prevention ICD indication.

Conditions

  • Cardiac Death

Interventions

DEVICE

device settings for group A

VT zone: 350ms VF zone: 280ms

DEVICE

Device settings for group B

VT zone: 320ms VF zone: 250ms

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Jörg O Schwab, Prof. Dr. med. · Medizinische Einrichtungen der Rheinischen Friedrich-Wilhelm-Universität Bonn

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2012-09-30
Completion
2013-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01217528 on ClinicalTrials.gov